Inspection Record

Vital Care of Dickson, LLC. — FDA 483 Findings

US FDAInspected 2020-03-11Published 2020-11-20 4 findingsOther quality systemAseptic processing and sterility assurance

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Procedures designed to prevent insanitary conditions are not established or followed.

2Aseptic processing and sterility assurance

Disinfecting agents used in the ISO 5 classified aseptic processing areas were not sterile.

3Aseptic processing and sterility assurance

Failure to conduct media fill studies that closely simulate aseptic processing operations under the worst-case, most-challenging and stressful conditions.

4Aseptic processing and sterility assurance

Pressure differentiaJs are not monitored in areas where aseptic processing occurs.

About this record

Extracted automatically from the document US FDA published on 2020-11-20. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Vital Care of Dickson, LLC. company profile — full history US FDA documents, 2020 Go to Findings search